Fresenius Medical Care Back to the Wall Run Reaches Kidney Health Awareness Goals While Creating History, Business News

JIAYUGUAN, CHINA – OutReach Media
– July 5, 2018 –
The extreme adventurer and philanthropist, David Grier, and his race
companion, Andrew Stuart, arrived in Jiayuguan this Tuesday,
the conclusion of their 4200-kilometer run of the Great Wall of China. the
run, which they undertook in partnership with Fresenius Medical
Care, the world's largest provider of dialysis products and
services, has created a wave of social media mobilization
across China and the Asia-Pacific, with thousands of people
follow the race of the pairs and take on the challenge of becoming more
active themselves.

A united front in promoting renal health awareness: Extreme
the adventurers David Grier (on the front) and Andrew Stuart
(left on the front) were joined by Fresenius Medical Care
Asia-Pacific CEO, Harry de Wit (middle) and some employees
the last kilometers of Back to the Wall Run.

Back to the Wall is a CSR initiative of Fresenius Medical
Care, aimed at raising public awareness about good kidney health through
Asia-Pacific through a partnership with adventurer David Grier
who took up the challenge of traveling all the way to the Great Wall
from China.

David, Harry, Andrew and Fresenius Medical Care employees are gone
the finish line together, marking the end of the 4200 km
challenge.

The return to the wall in China, which aims to raise the kidney
health awareness, was concluded this Tuesday.

David, Harry and Andrew poured water that they brought
Shanhaiguan, the starting point of the trip, in the river
Jiayuguan, marking the end of this 3 month trip.

David Grier first ran the Great Wall of China 12 years ago, with
his trip from Jiayuguan City. By completing the race today
– In the other direction – David became the first
to run the Great Wall of China in both directions.

million. Harry de Wit, CEO of Fresenius Medical Care Asia-Pacific, and 10
company employees ran the last kilometers of the Great Wall with
David and Andrew. They converged with the guest runners of the
the local health care industry to cross the finish line together,
bringing the historic race to an end.

Speaking at the closing ceremony, Mr. de Wit thanked David
and Andrew, and all those who participated in the social society
responsibility campaign: "I'm proud to have run the last stage of
today's trip, "he said. I hope that strength and strength
that these men have shown will inspire every individual and every
person living with CKD to believe in themselves and conquer their
own & # 39; Great Wall & # 39; with a positive attitude. The closing ceremony of today
is not an end; it's a whole new beginning. "

David Grier echoed this sentiment, encouraging the wider community
use the program WeChat Great Wall developed by Fresenius Medical
Care China, where players accumulate daily steps as they do virtually
launch the Great Wall: "Put on your shoes and start counting your own
not. The steps do not stop when we reach the end of the wall, this
That's where the proceedings begin, "he said.

Alan Chen,
Executive Vice President, Fresenius Medical Care China
, highlighted the ways in which the campaign has succeeded in
chronic kidney disease in the national health program. "I was very
happy to see how the Back to the Wall campaign was able to reach
through China, "he said. Outreach events in Yulin and Kunming
received great support from local medical associations, hospitals
and patients. In addition, we open dialysis centers
Fujian, Yunnan and Sichuan to support facilities in public
hospitals. This corresponds to the government's strategy of allocating
quality medical resources in urban and rural areas,
more people living with chronic kidney disease to access the essentials
services."

Very important, the reach of the campaign has extended well beyond
China, raise awareness of kidney health throughout the
Asia Pacific Region. During the rest of the year 2018, Fresenius
Medical Care Will Engage Employees, Patients And Health Care
professionals in fun races, walks and educational events across the
region, and amplifying their messages on kidney health through
social media networks.

In a video interview just before ending the race, David
reflected on the Great Wall as a metaphor for the obstacles we all face
in our lives: "For each of us, our lives are littered with
walls that block the ultimate dream of how we see our lives
deployment. I think the Great Wall race is symbolic to the
walls faced by people living with CKD: No matter how traitorous
the front wall, the depth of the craters and the friability of the road,
never leave your trip. Put your hand to the friend
it's there with you, and travels the journey together. You will be
arrive at the end of this wall. "

Video link:
https://www.facebook.com/dmmgrier/videos/10156423851133249/

ABOUT DAVID GRIER AND THE ANDREW STUART JOURNAL

Y

David Grier and Andrew Stuart began their journey to run the ensemble
route of the Great Wall of China at the end of March 2018.
Starting in Shanhaiguan, the pair ran an average of 61 kilometers
one day and arrived at their final destination in Jiayuguan on the 3rd
July. Twelve years ago, David became one of the first
history of running all the way to the Great Wall of China, and he
has now repeated history by becoming the first person in history to
run the wall in both directions.

ABOUT FRESENIUS MEDICAL CARE

Fresenius Medical Care is the world's largest supplier of products
and services for people with kidney disease
3.2 million patients worldwide are regularly dialyzed
treatment. Through its network of 3,790 dialysis clinics, Fresenius
Medical Care Provides Dialysis Treatments for 322,253 Patients
around the globe. Fresenius Medical Care is also the leader
provider of dialysis products such as dialysis machines or
dialyzers. In addition to its core business, the company provides
related medical services in the field of care coordination.
Fresenius Medical Care is listed on the Frankfurt Stock Exchange
(FME) and the New York Stock Exchange (FMS).

NOTICE OF DISCLAIMER

This version contains forward-looking statements that are subject to
various risks and uncertainties. Actual results may differ
materially from those described in these forward-looking statements
because of certain factors, including changes in business, economic and
competitive conditions, regulatory reforms, exchange rate
fluctuations, uncertainties in litigation or investigation
procedures, and the availability of funding. These and others
Risks and uncertainties are detailed in Fresenius Medical Care AG
Reports of & Co. KGaA filed with US securities and
Commission of exchange. Fresenius Medical Care AG and Co. KGaA
not take responsibility for updating the future
statements in this version.